dcsimg Aranesp® (darbepoetin alfa) – Dose Combinations Tool
› Email› Print

Aranesp® single-dose strengths can be combined to more
precisely titrate doses and individualize anemia management
for patients with CKD on dialysis

Aranesp® is also available in 150, 200, 300, and 500 mcg dose strengths.

The 10, 150, and 500 mcg dose strengths are available only as prefilled syringes.

Simply select one of the following doses to see which single-dose strengths may be combined to individualize anemia management

Aranesp® single-dose strengths

Important Safety Information

  • Serious allergic reactions, including anaphylactic reactions, angioedema, bronchospasm, skin rash, and urticaria may occur with Aranesp®. Immediately and permanently discontinue Aranesp® if a serious allergic reaction occurs.
  • Adverse reactions (≥ 10%) in Aranesp® clinical studies in patients with CKD were hypertension, dyspnea, peripheral edema, cough, and procedural hypotension.

Scroll down for additional
Important Safety Information.

Abbreviations and References:
CKD = chronic kidney disease.

Biotechnology by Amgen®